Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,500
Closed -$12K 7828
2015
Q4
$12K Hold
2,500
﹤0.01% 7173
2015
Q3
$7K Hold
2,500
﹤0.01% 7496
2015
Q2
$11K Hold
2,500
﹤0.01% 7387
2015
Q1
$9K Buy
2,500
+400
+19% +$1.36K ﹤0.01% 7715
2014
Q4
$7K Buy
+2,100
New +$5.81K ﹤0.01% 8700

Other funds holding GERN

UBS Group's GERN Position: Q2 2026 in Review

UBS Group increased its Geron (GERN) stake by 33% in Q2 2026, buying an estimated $1.69M and bringing the position to 4,896,096 shares worth $6.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3925.

UBS Group first reported a position in GERN in Q4 2014 and has held it in 47 quarters since. The position peaked at $23.4M in Q4 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • UBS Group held 4,896,096 shares of Geron worth $6.27M as of Q2 2026.
  • UBS Group bought 1,202,763 Geron shares in Q2 2026, an estimated $1.69M.
  • Geron made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3925 holding.
  • UBS Group first reported a position in Geron in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Geron position peaked at $23.4M in Q4 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.